+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Heart Failure Therapeutics Market Intelligence Report - Global Forecast 2023-2030

  • PDF Icon

    Report

  • 180 Pages
  • January 2023
  • Region: Global
  • Think Market Intelligence
  • ID: 5670059
UP TO OFF until Mar 31st 2023
The Global Heart Failure Therapeutics Market is projected to reach USD 48.13 billion by 2030 from USD 22.06 billion in 2022, at a CAGR 10.23% during the forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions.

In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

  • The Americas Heart Failure Therapeutics Market size was estimated at USD 7,225.80 million in 2022 and expected to reach USD 7,868.70 million in 2023, at a CAGR 10.29% to reach USD 15,825.19 million by 2030.
  • The Asia-Pacific Heart Failure Therapeutics Market size was estimated at USD 6,458.26 million in 2022 and expected to reach USD 7,011.60 million in 2023, at a CAGR 10.21% to reach USD 14,058.82 million by 2030.
  • The Europe, Middle East & Africa Heart Failure Therapeutics Market size was estimated at USD 8,384.15 million in 2022 and expected to reach USD 9,101.23 million in 2023, at a CAGR 10.20% to reach USD 18,246.14 million by 2030.

Market Segmentation & Coverage:

The report on the Global Heart Failure Therapeutics Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan.

This research report categorizes the Global Heart Failure Therapeutics Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:

Treatment:

  • Medical Devices
    • Bi-level positive air pressure device
    • Biventricular Pacemaker
    • Continuous Positive Air Pressure Device
    • Heart Pumps
    • Implantable Cardioverter-Defibrillators
    • Implantable Left Ventricular Assist Device
  • Medicines
    • Angiotensin II Receptor Blockers
    • Anticoagulant Medicines
    • Antiplatelet Medicines
    • Blood Pressure Maintaining Agents
    • Diuretics
    • Nitrates
    • Statins
  • Surgery
    • Cardiac Resynchronization
    • Coronary Artery Bypass Grafting
    • Coronary Revascularization
    • Heart Transplant
    • Heart Valve Replacement

Type:

  • Diagnosis
  • Prognosis

Stage:

  • Stage A
  • Stage B
  • Stage C
  • Stage D

End User:

  • Clinic
  • Hospital
  • Medical Research Organization

Region:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

Company Usability Profiles:

  • Abbott Laboratories
  • ABIOMED, Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Beckman Coulter, Inc.
  • Berlin Heart GmbH
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Company
  • Cardiol Therapeutics Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Impulse Dynamics
  • Jarvik Heart, Inc.
  • Johnson & Johnson
  • LivaNova, PLC
  • Medtronic PLC
  • Merck & Co., Inc.
  • Novartis AG
  • Orion Corporation
  • Pfizer, Inc.
Frequently Asked Questions about the Global Heart Failure Therapeutics Market

What is the estimated value of the Global Heart Failure Therapeutics Market?

The Global Heart Failure Therapeutics Market was estimated to be valued at $22.06 Billion in 2022.

What is the growth rate of the Global Heart Failure Therapeutics Market?

The growth rate of the Global Heart Failure Therapeutics Market is 10.2%, with an estimated value of $48.13 Billion by 2030.

What is the forecasted size of the Global Heart Failure Therapeutics Market?

The Global Heart Failure Therapeutics Market is estimated to be worth $48.13 Billion by 2030.

Who are the key companies in the Global Heart Failure Therapeutics Market?

Key companies in the Global Heart Failure Therapeutics Market include Abbott Laboratories, ABIOMED, Inc., Amgen Inc., AstraZeneca PLC, Bayer AG, Beckman Coulter, Inc., Berlin Heart GmbH, Boston Scientific Corporation and Myers Squibb Company.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Market Overview

4. Americas Heart Failure Therapeutics Market
4.1. Introduction
4.2. Argentina
4.3. Brazil
4.4. Canada
4.5. Mexico
4.6. United States

5. Asia-Pacific Heart Failure Therapeutics Market
5.1. Introduction
5.2. Australia
5.3. China
5.4. India
5.5. Indonesia
5.6. Japan
5.7. Malaysia
5.8. Philippines
5.9. Singapore
5.10. South Korea
5.11. Taiwan
5.12. Thailand
5.13. Vietnam

6. Europe, Middle East & Africa Heart Failure Therapeutics Market
6.1. Introduction
6.2. Denmark
6.3. Egypt
6.4. Finland
6.5. France
6.6. Germany
6.7. Israel
6.8. Italy
6.9. Netherlands
6.10. Nigeria
6.11. Norway
6.12. Poland
6.13. Qatar
6.14. Russia
6.15. Saudi Arabia
6.16. South Africa
6.17. Spain
6.18. Sweden
6.19. Switzerland
6.20. Turkey
6.21. United Arab Emirates
6.22. United Kingdom

7. Competitive Landscape
7.1. FPNV Positioning Matrix
7.1.1. Quadrants
7.1.2. Business Strategy
7.1.3. Product Satisfaction
7.2. Market Ranking Analysis, By Key Player
7.3. Market Share Analysis, By Key Player
7.4. Product Portfolio Analysis, By Key Player
7.5. Competitive Scenario
7.5.1. Merger & Acquisition
7.5.2. Agreement, Collaboration, & Partnership
7.5.3. New Product Launch & Enhancement
7.5.4. Investment & Funding
7.5.5. Award, Recognition, & Expansion

8. Company Usability Profiles
8.1. Abbott Laboratories
8.2. ABIOMED, Inc.
8.3. Amgen Inc.
8.4. AstraZeneca PLC
8.5. Bayer AG
8.6. Beckman Coulter, Inc.
8.7. Berlin Heart GmbH
8.8. Boston Scientific Corporation
8.9. Bristol-Myers Squibb Company
8.10. Cardiol Therapeutics Inc.
8.11. F. Hoffmann-La Roche Ltd.
8.12. GlaxoSmithKline PLC
8.13. Impulse Dynamics
8.14. Jarvik Heart, Inc.
8.15. Johnson & Johnson
8.16. LivaNova, PLC
8.17. Medtronic PLC
8.18. Merck & Co., Inc.
8.19. Novartis AG
8.20. Orion Corporation
8.21. Pfizer, Inc.

9. Appendix
9.1. Discussion Guide
9.2. License & Pricing


List of Figures
FIGURE 1. GLOBAL HEART FAILURE THERAPEUTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HEART FAILURE THERAPEUTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 4. GLOBAL HEART FAILURE THERAPEUTICS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HEART FAILURE THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 6. GLOBAL HEART FAILURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 7. GLOBAL HEART FAILURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL HEART FAILURE THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 9. AMERICAS HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 10. AMERICAS HEART FAILURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 11. AMERICAS HEART FAILURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS HEART FAILURE THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 13. ARGENTINA HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 14. BRAZIL HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 15. CANADA HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 16. MEXICO HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 17. UNITED STATES HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 18. UNITED STATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 19. UNITED STATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 20. UNITED STATES HEART FAILURE THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 21. ASIA-PACIFIC HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 22. ASIA-PACIFIC HEART FAILURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 23. ASIA-PACIFIC HEART FAILURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 24. ASIA-PACIFIC HEART FAILURE THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 25. AUSTRALIA HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 26. CHINA HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 27. INDIA HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 28. INDONESIA HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 29. JAPAN HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 30. MALAYSIA HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 31. PHILIPPINES HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 32. SINGAPORE HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 33. SOUTH KOREA HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 34. TAIWAN HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 35. THAILAND HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 36. VIETNAM HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 37. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 38. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 39. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 40. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 41. DENMARK HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 42. EGYPT HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 43. FINLAND HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 44. FRANCE HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 45. GERMANY HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 46. ISRAEL HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 47. ITALY HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 48. NETHERLANDS HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 49. NIGERIA HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 50. NORWAY HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 51. POLAND HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 52. QATAR HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 53. RUSSIA HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 54. SAUDI ARABIA HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 55. SOUTH AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 56. SPAIN HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 57. SWEDEN HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 58. SWITZERLAND HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 59. TURKEY HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 60. UNITED ARAB EMIRATES HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 61. UNITED KINGDOM HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 62. GLOBAL HEART FAILURE THERAPEUTICS MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 63. GLOBAL HEART FAILURE THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 64. GLOBAL HEART FAILURE THERAPEUTICS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. GLOBAL HEART FAILURE THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HEART FAILURE THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL HEART FAILURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. AMERICAS HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 7. AMERICAS HEART FAILURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 8. AMERICAS HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 9. AMERICAS HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 10. AMERICAS HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 11. AMERICAS HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 12. ARGENTINA HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 13. ARGENTINA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 14. ARGENTINA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 15. ARGENTINA HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 16. ARGENTINA HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 17. BRAZIL HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 18. BRAZIL HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 20. BRAZIL HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 21. BRAZIL HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 22. CANADA HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 23. CANADA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 24. CANADA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. CANADA HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 26. CANADA HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. MEXICO HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 28. MEXICO HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 29. MEXICO HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. MEXICO HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 31. MEXICO HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC HEART FAILURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 48. AUSTRALIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. CHINA HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 50. CHINA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 51. CHINA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. CHINA HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 53. CHINA HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. INDIA HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 55. INDIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 56. INDIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. INDIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 58. INDIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. INDONESIA HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 60. INDONESIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 61. INDONESIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. INDONESIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. JAPAN HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 65. JAPAN HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 66. JAPAN HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. JAPAN HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 68. JAPAN HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. MALAYSIA HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 70. MALAYSIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. PHILIPPINES HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. THAILAND HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 95. THAILAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 96. THAILAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. THAILAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 98. THAILAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. DENMARK HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 111. DENMARK HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 112. DENMARK HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. DENMARK HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 114. DENMARK HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. EGYPT HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 116. EGYPT HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 117. EGYPT HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. EGYPT HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 119. EGYPT HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. FINLAND HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 121. FINLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 122. FINLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. FINLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 124. FINLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. FRANCE HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 126. FRANCE HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 127. FRANCE HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. FRANCE HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 129. FRANCE HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. GERMANY HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 131. GERMANY HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 132. GERMANY HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. GERMANY HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 134. GERMANY HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. ISRAEL HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 136. ISRAEL HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 137. ISRAEL HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. ISRAEL HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 139. ISRAEL HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. ITALY HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 141. ITALY HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 142. ITALY HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. ITALY HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 144. ITALY HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. NETHERLANDS HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 146. NETHERLANDS HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 147. NETHERLANDS HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. NETHERLANDS HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 149. NETHERLANDS HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. NIGERIA HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 151. NIGERIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 152. NIGERIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. NIGERIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 154. NIGERIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. NORWAY HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 156. NORWAY HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 157. NORWAY HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 158. NORWAY HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 159. NORWAY HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. POLAND HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 161. POLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 162. POLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 163. POLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 164. POLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. QATAR HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 166. QATAR HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 167. QATAR HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. QATAR HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 169. QATAR HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 176. SAUDI ARABIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 177. SAUDI ARABIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. SOUTH AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. SPAIN HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 186. SPAIN HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 187. SPAIN HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 188. SPAIN HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 189. SPAIN HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. SWEDEN HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 191. SWEDEN HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 192. SWEDEN HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 193. SWEDEN HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 194. SWEDEN HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. SWITZERLAND HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 196. SWITZERLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 197. SWITZERLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 198. SWITZERLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 199. SWITZERLAND HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. TURKEY HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 201. TURKEY HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 202. TURKEY HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 203. TURKEY HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 204. TURKEY HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM HEART FAILURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM HEART FAILURE THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 212. UNITED KINGDOM HEART FAILURE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM HEART FAILURE THERAPEUTICS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 214. UNITED KINGDOM HEART FAILURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. GLOBAL HEART FAILURE THERAPEUTICS MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 216. GLOBAL HEART FAILURE THERAPEUTICS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 217. GLOBAL HEART FAILURE THERAPEUTICS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 218. GLOBAL HEART FAILURE THERAPEUTICS MARKET RANKING, BY KEY PLAYER, 2022
TABLE 219. GLOBAL HEART FAILURE THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 220. GLOBAL HEART FAILURE THERAPEUTICS MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 221. GLOBAL HEART FAILURE THERAPEUTICS MARKET MERGER & ACQUISITION
TABLE 222. GLOBAL HEART FAILURE THERAPEUTICS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 223. GLOBAL HEART FAILURE THERAPEUTICS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 224. GLOBAL HEART FAILURE THERAPEUTICS MARKET INVESTMENT & FUNDING
TABLE 225. GLOBAL HEART FAILURE THERAPEUTICS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 226. GLOBAL HEART FAILURE THERAPEUTICS MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • ABIOMED, Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Beckman Coulter, Inc.
  • Berlin Heart GmbH
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Company
  • Cardiol Therapeutics Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Impulse Dynamics
  • Jarvik Heart, Inc.
  • Johnson & Johnson
  • LivaNova, PLC
  • Medtronic PLC
  • Merck & Co., Inc.
  • Novartis AG
  • Orion Corporation
  • Pfizer, Inc.

Methodology

Loading
LOADING...